Ningxia will realize Electronic Supervision of Drug production and Marketing
Xinhua News Agency, Yinchuan, 17 Nov (Reporter Zou Xinyuan and Fan Sixiang) the reporter recently learned from the Drug Administration of Ningxia Hui Autonomous region that Ningxia has promoted the information construction of drug intelligence supervision this year. Based on the autonomous region e-government platform and other networks to build drug intelligence supervision platform. It is expected that by the end of this year, Ningxia will realize the electronic supervision of drug production and marketing.
According to reports, with the continuous development of "Internet + supervision" and other technical means, this year, the Autonomous region Drug Regulatory Bureau innovated the traditional way of supervision and effectively promoted the collection and integration of drug regulatory information and risk early warning. A drug safety information supervision service system covering all levels of drug safety supervision departments, relevant management departments and facing the public will be built.
The autonomous region drug intelligence supervision platform will be composed of nine modules, such as daily supervision system, inspection and law enforcement system, inspection and detection system, credit management system, public service system, drug traceability system, big data distributed cloud platform and so on. With the help of this platform, Ningxia will realize the information and meticulous supervision of drug production and management.
After the completion and operation of the platform, through interaction with the public, Ningxia regulatory departments can form a more timely and accurate study and judgment of drug safety problems, and reduce the difficulty of drug source tracing. With the establishment of the Drug big data Center, multi-government departments to achieve connectivity, data sharing, improve regulatory efficiency, inspection efficiency, so that the production and operation of drugs more standardized, so that the public to buy drugs at ease, drug use at ease.